Proapoptotic nuclear receptor family member Nur77 translocates from the nucleus to the mitochondria, where it interacts with Bcl-2 to trigger apoptosis. Nur77 translocation is induced by certain apoptotic stimuli, including the synthetic retinoid-related 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN)/ CD437 class. In this study, we investigated the molecular mechanism by which AHPN/CD437 analog (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induces Nur77 nuclear export. Our results demonstrate that 3-Cl-AHPC effectively activated Jun N-terminal kinase (JNK), which phosphorylates Nur77. Inhibition of JNK activation by a JNK inhibitor suppressed 3-Cl-AHPC-induced Nur77 nuclear export and apoptosis. In addition, several JNK upstream activators, including the phorbol ester TPA, anisomycin and MAPK kinase kinase-1 (MEKK1), phosphorylated Nur77 and induced its nuclear export. However, Nur77 phosphorylation by JNK, although essential, was not sufficient for inducing Nur77 nuclear export. Induction of Nur77 nuclear export by MEKK1 required a prolonged MEKK1 activation and was attenuated by Akt activation. Expression of constitutively active Akt prevented MEKK1-induced Nur77 nuclear export. Conversely, transfection of dominant-negative Akt or treatment with a phosphatidylinositol 3-kinase (PI3-K) inhibitor accelerated MEKK1-induced Nur77 nuclear export. Furthermore, mutation of an Akt phosphorylation residue Ser351 in Nur77 abolished the effect of Akt or the PI3-K inhibitor. Together, our results demonstrate that both activation of JNK and inhibition of Akt play a role in translocation of Nur77 from the nucleus to the cytoplasm.
Introduction
Nur77 (also known as TR3 or NGFI-B), an orphan member of the nuclear receptor superfamily (Hazel et al., 1988; Milbrandt, 1988; Chang et al., 1989) , exerts opposing biological activities, survival and death, in response to extracellular stimuli (Zhang, 2002) . The mitogenic effect of Nur77 likely occurs in the nucleus as it requires Nur77 DNA-binding and transactivation (Kolluri et al., 2003) . A chimeric protein involving Nur77 subfamily member Nor-1 from a chromosomal translocation in chondrosarcoma is a potent transcriptional activator, suggesting that Nur77 transcriptional activation may be oncogenic (Labelle et al., 1995 (Labelle et al., , 1999 . Consistently, Nur77 is one of the 17-gene-signature genes associated with metastasis of several primary solid tumors (Ramaswamy et al., 2003) . Nuclear Nur77 binds to specific response elements, NBRE and NurRE, either as a monomer or homodimer (Wilson et al., 1991; Philips et al., 1997) . In addition, Nur77 regulates transcriptional responses to retinoids by heterodimerizing with orphan nuclear receptor COUP-TF (Wu et al., 1997b) and retinoid X receptor (RXR) (Forman et al., 1995; Perlmann and Jansson, 1995; Wu et al., 1997a) .
The proapoptotic effect of Nur77 has received much attention recently. Nur77 expression is rapidly induced during apoptosis of immature thymocytes, T-cell hybridomas and various cancer cell types (Liu et al., 1994; Woronicz et al., 1994; Li et al., 1998 Li et al., , 2000 Milbrandt, 1988; Uemura and Chang, 1998) . We have previously demonstrated a new paradigm in cancer cell apoptosis, in which Nur77 is induced, then translocates from the nucleus to the mitochondria, leading to release of cytochrome c from the mitochondria (Li et al., 2000) . The apoptosis-associated nuclear egress of Nur77 has been observed in cancer cells from the lung, ovary, colon, stomach and breast (Dawson et al., 2001; Holmes et al., 2002 Holmes et al., , 2003 Liu et al., 2002; Wu et al., 2002; Jeong et al., 2003; Kolluri et al., 2003; Wilson et al., 2003; Cao et al., 2004; Jacobs et al., 2004; Lin et al., 2004; Lee et al., 2005) . Nur77 mitochondrial localization is also involved in Sindbis virus-induced apoptosis (Lee et al., 2002) . Translocation of Nur77 from the nucleus to the cytoplasm is regulated by its unique heterodimerization with RXRa , and once in the cytoplasm, Nur77 targets mitochondria through its interaction with mitochondrial Bcl-2 . The interaction between Nur77 and Bcl-2 induces a Bcl-2 conformational change, leading to conversion of Bcl-2 from an antiapoptotic to a proapoptotic molecule . These findings establish a novel Bcl-2-dependent Nur77 apoptotic pathway, which plays an important role in regulating apoptosis of cancer cells in response to certain extracellular stimuli.
The Nur77-dependent apoptotic process is triggered by a number of apoptosis inducers, including retinoidrelated molecule 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalenecar-boxylic acid (AHPN) (also called CD437) (Li et al., 2000) and its analogs (Li et al., 2000; Dawson et al., 2001; Holmes et al., 2002 Holmes et al., , 2003 Kolluri et al., 2003; Cao et al., 2004; Lin et al., 2004) , etoposide (Li et al., 2000; Liu et al., 2002; Wilson et al., 2003) , and insulin-like growth factor binding protein-3 (Lee et al., 2005) . The importance of Nur77-dependent apoptotic pathway in mediating the anticancer activity of chemotherapeutic agents is supported by the positive correlation between Nur77 family member Nor-1 expression and survival in diffuse large B-cell lymphoma patients treated with therapeutic drugs (Shipp et al., 2002) .
How apoptotic stimuli induce Nur77 translocation from the nucleus to the mitochondria remains largely unknown. Nur77 mitochondrial targeting is induced by apoptotic retinoid-related compounds, TPA, a calcium ionophore, and chemotherapeutic agents, which are known to act through membrane-signaling pathways involving various kinases and phosphatases (Li et al., 2000; Kolluri et al., 2003) . Thus, phosphorylation may play a role in regulating Nur77 subcellular trafficking. In fact, Nur77 is heavily phosphorylated in various cell types and phosphorylation regulates Nur77 functions (Fahrner et al., 1990; Hazel et al., 1991; Davis et al., 1993; Hirata et al., 1993; Weih et al., 1996; Katagiri et al., 2000; Masuyama et al., 2001; Pekarsky et al., 2001; Kolluri et al., 2003) . Nur77 is phosphorylated at its N-terminal A/B domain by Jun N-terminal kinase (JNK) (Kolluri et al., 2003) and at Ser350 (Ser351 in human Nur77) by Akt (Masuyama et al., 2001; Pekarsky et al., 2001) . Nur77 phosphorylation by JNK and Akt modulates its DNA-binding and transactivation functions (Masuyama et al., 2001; Pekarsky et al., 2001; Kolluri et al., 2003) . The role of phosphorylation in Nur77 nuclear export is demonstrated by the finding that nerve growth factor (NGF)-induced NGFI-B nuclear export requires the phosphorylation of NGFI-B at Ser105 (Ser140 in human Nur77) by MAP kinase pathway (Katagiri et al., 2000) . Whether Nur77 phosphorylation by JNK and Akt regulates its subcellular localization remains to be determined.
AHPN and its analogs are a class of retinoid-related compounds that effectively induce apoptosis of many cancer types (Schadendorf et al., 1995; Shao et al., 1995; Li et al., 1996 Li et al., , 1998 Li et al., , 2000 Oridate et al., 1997; Widschwendter et al., 1997; Hsu et al., 1997a, b; Adachi et al., 1998; Dawson et al., 1998; Langdon et al., 1998; Gianni and de The, 1999; Liang et al., 1999; Sun et al., 1999; Holmes et al., 2002) . They are known to activate JNK (Zhang et al., , 2003 Wan et al., 2001; Garattini et al., 2004; Boisvieux-Ulrich et al., 2005) , which is required for maximal apoptosis induction and precedes mitochondrial depolarization. Induction of apoptosis of breast and prostate cancer cells by AHPN is also associated with its inhibition of Akt activity (Farhana et al., 2004) .
We previously reported that AHPN and its analog (E)-4-[3-(1-adamantyl)-4-hydroxyphenyl]-3-chlorocinnamic acid (3-Cl-AHPC) induced Nur77 mitochondrial targeting in prostate cancer and lung cancer cells (Dawson et al., 2001; Kolluri et al., 2003; Cao et al., 2004) . Similar results were shown in ovarian cancer cells (Holmes et al., 2002 (Holmes et al., , 2003 . Interestingly, removal of the Nur77 N-terminal amino-acid sequences, which are subject to phosphorylation by JNK (Kolluri et al., 2003) , produced a mutant (Nur77/D1) that failed to respond to treatment by an AHPN analog with respect to its undergoing nuclear export and inducing apoptosis (Li et al., 2000) . These findings prompted us to hypothesize that AHPN-induced Nur77 nuclear export involves JNK activation. Here, we report that phosphorylation of Nur77 by JNK is required for 3-Cl-AHPC-induced Nur77 nuclear export and apoptosis. By using various upstream JNK activators and JNK inhibitor, we found that JNK activation was essential for inducing Nur77 nuclear export. However, induction of Nur77 nuclear export by JNK required other signaling pathways or protein factors. In response to MEKK1 activation, Nur77 phosphorylation by JNK resulted in a delayed Nur77 nuclear export, which was accelerated by inhibition of Akt activity. 3-Cl-AHPC also effectively inhibited Akt activation in cells where it induced Nur77 nuclear export. Thus, both induction of JNK and inhibition of Akt phosphorylation of Nur77 contribute to induction of Nur77 nuclear export.
Results
Activation of JNK by AHPN analog 3-Cl-AHPC We previously reported that the N-terminal A/B domain of Nur77 mediated the effect of apoptotic stimuli on inducing Nur77 nuclear export (Li et al., 2000) and was phosphorylated by JNK (Kolluri et al., 2003) . To study whether JNK phosphorylation of Nur77 plays a role in mediating the effect of 3-Cl-AHPC on inducing Nur77 nuclear export and Nur77-dependent apoptosis (Dawson et al., 2001; Kolluri et al., 2003; Cao et al., 2004) , we examined the effect of 3-Cl-AHPC on JNK activation. A panel of cancer cell lines, including H460, H292 and A549 lung cancer, LNCaP prostate cancer, and MDA-MB-231 breast cancer cells, were treated with 3-Cl-AHPC, and the activation of JNK was evaluated by an in vitro JNK kinase assay. Treatment of these cells with 3-Cl-AHPC for 1 h resulted in strong activation of JNK ( Figure 1a ). For comparison, JNK activation by UV exposure was shown. As Nur77 protein induced by 3-Cl-AHPC was heavily phosphorylated, displaying several high-molecular-weight bands on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Kolluri et al., 2003) , the finding that 3-Cl-AHPC strongly activates JNK suggests that 3-Cl-AHPCinduced Nur77 protein may be phosphorylated by JNK. 2 ) is shown. Levels of GST-cJun phosphorylation were determined by scanning X-ray films obtained in three independent experiments (mean values7s.d.). (b) JNK inhibitor inhibits 3-Cl-AHPC-induced apoptosis. H460 cells were treated for 48 h with 3-Cl-AHPC (1 mM) in the presence or absence of JNK inhibitor II (4 mg/ml). Apoptotic cells were scored by examining 300 cells for nuclear fragmentation and chromatin condensation, and apoptosis indicated as a percentage of total cells is given in parenthesis. (c) JNK inhibitor inhibits 3-Cl-AHPC-induced nuclear export of endogenous Nur77. H460 cells or H460 cells stably expressing Nur77 antisense RNA were treated with 3-Cl-AHPC (1 mM) in the presence or absence of JNK inhibitor II for 3 h, then immunostained with anti-Nur77 antibody followed by Cy3-conjugated secondary antibody. Cells were also stained with DAPI to identify nuclei. Nur77 and nuclei were visualized using confocal microscopy, and the images were overlaid. Nur77 was stained in the cytoplasm in about 40% of 3-Cl-AHPC-treated cells that were counted.
We next examined whether JNK activation was required for the apoptotic effect of 3-Cl-AHPC. Treatment of H460 lung cancer cells with 3-Cl-AHPC for 24 h resulted in 57.6% apoptosis (Figure 1b) . Cotreatment of cells with a JNK inhibitor almost completely suppressed the apoptotic effect of 3-Cl-AHPC, with only 8.7% apoptosis. Similar results were obtained in other cancer cells lines (data not shown). Thus, JNK activation is essential for the apoptotic effect of 3-Cl-AHPC in H460 lung cancer cells.
Nur77 expression is required for the apoptotic effect of AHPN in H460 lung cancer cells (Li et al., 1998) . The observation that JNK inhibitor effectively suppressed 3-Cl-AHPC-induced apoptosis in these cells suggested that JNK might modulate Nur77 apoptotic activity. As Nur77 nuclear export is essential for the apoptotic effect of 3-Cl-AHPC in H460 cells (Kolluri et al., 2003; Cao et al., 2004; Lin et al., 2004) , we examined whether JNK activation by 3-Cl-AHPC was involved in Nur77 nuclear export. H460 cells were treated with 3-Cl-AHPC in the absence or presence of a JNK inhibitor, then immunostained with an anti-Nur77 antibody ( Figure 1c ). Consistent with its induction of Nur77 expression (Li et al., 1998 (Li et al., , 2000 , 3-Cl-AHPC strongly enhanced Nur77 immunostaining, which was localized in the cytoplasm. Nur77 immunostaining was specific because the anti-Nur77 antibody failed to stain 3-Cl-AHPC-treated H460 cells stably expressing Nur77 antisense RNA. 3-Cl-AHPC-induced cytoplasmic localization of Nur77 was largely prevented when cells were treated with the JNK inhibitor. Thus, JNK activation is involved in the induction of Nur77 nuclear export by 3-Cl-AHPC.
TPA-induced Nur77 phosphorylation and nuclear export involve JNK activation To provide further evidence supporting the role of JNK activation, we examined whether JNK was involved in Nur77 phosphorylation in response to TPA, which also induced Nur77 nuclear export (Li et al., 2000; Lin et al., 2004) . Consistent with our previous report (Li et al., 2000; Kolluri et al., 2003; Cao et al., 2004; Lin et al., 2004) , treatment of H460 cells with TPA strongly induced Nur77 expression, as revealed by immunoblotting ( Figure 2a ). The TPA-induced Nur77 protein displayed multiple bands on SDS-PAGE, suggesting that Nur77 underwent post-translational modification. The Figure 2 Phosphorylation of Nur77 by apoptotic stimuli is JNK-dependent. (a) Induction of Nur77 and its characterization. H460 cells were treated with TPA (100 ng/ml) for 3 h with or without JNK inhibitor II (20 mM), p38 inhibitor SB203580 (20 mM), or MEK1 inhibitor PD98059 (20 mM). Expression of Nur77 was determined by immunoblotting using anti-Nur77 antibody. TPA-treated cell extracts were also incubated with AP to determine whether the multiple bands observed after the induction of Nur77 represented phosphorylated forms. (b) Phosphorylation of Nur77 is induced by TPA and anisomycin. HEK293T cells were transfected with CMVNur77 plasmid and treated with TPA (100 ng/ml) or anisomycin (10 ng/ml) for 3 h. Cell extracts were analysed by immunoblotting using anti-Nur77 antibody. The electrophoretic mobility of overexpressed Nur77 was shifted by TPA or anisomycin treatment, suggesting that TPA and anisomycin induced Nur77 protein phosphorylation. (c) Confirmation of Nur77 phosphorylation by AP treatment. HEK293T cells were transfected with CMV-Nur77 plasmid and treated with TPA or anisomycin for 3 h. Cell extracts were treated with or without AP and analysed by immunoblotting using anti-Nur77 antibody. (d) Characterization of Nur77 protein phosphorylation induced by anisomycin. HEK293T cells transfected with Myc-Nur77 were treated with anisomycin (10 ng/ml) for 3 h with or without 20 mM of JNK inhibitor II, SB203580 or PD98059. Expression of Myc-Nur77 was determined by immunoblotting using anti-Myc antibody. The specificity of inhibitors was determined by using antibodies against phospho-c-Jun, phospho-p38, and phospho-ERK1/2. (e) Anisomycin induces Nur77 nuclear export. Flag-Nur77 was transfected into HEK293T cells, which were then treated with anisomycin (10 ng/ml) for 3 h. Cytoplasmic (C) and nuclear (N) fractions were prepared and analysed by immunoblotting using anti-Flag antibody. Expression of nuclear protein PARP and cytoplasmic protein Hsp60 was used to establish the purity of subcellular fractions.
Regulation of Nur77 nuclear export by JNK and Akt Y-H Han et al modification of Nur77 protein by phosphorylation was illustrated by the alkaline phosphatase (AP) treatment of cell extracts prepared from TPA-treated cells, which caused the disappearance of the higher molecular weight Nur77 bands (Figure 2a ). TPA is known to activate protein kinase C, which then activates various signal transduction pathways, including those involved in JNK activation (Hunter and Karin, 1992) . To study whether JNK activation had a role in TPA-induced Nur77 phosphorylation, H460 cells were treated with TPA in the presence or absence of chemical inhibitors of different kinases known to be activated by TPA, including JNK inhibitor, the specific MEK1 inhibitor PD98059 and the p38 inhibitor SB203580. These inhibitors had a reasonable degree of specificity and functioned properly in blocking their respective known targets (see below). Cotreatment of cells with TPA and JNK inhibitor or PD98059 significantly reduced the intensity of the higher molecular weight Nur77 bands induced by TPA (Figure 2a ), while cotreatment with SB203580 had no effect. These results demonstrate that phosphorylation of Nur77 induced by TPA involves JNK and ERK, suggesting again the involvement of JNK phosphorylation of Nur77 in its nuclear export.
JNK activator anisomycin induces Nur77 phosphorylation and nuclear export
Although JNK inhibitor is widely used to study signal transduction, it has a poor specificity (Bain et al., 2003) . To further determine the involvement of JNK, we examined whether anisomycin, another JNK activator (Tournier et al., 2000) , induced the phosphorylation of Nur77 and regulated its subcellular localization. The Nur77 expression plasmid was transfected into HEK293T cells, which were then treated with or without anisomycin. For comparison, Nur77-transfected cells were also treated with TPA. Immunoblotting analysis showed that the transfected Nur77 displayed multiple bands on SDS-PAGE (Figure 2b ), suggesting its posttranslational modification by endogenous kinase(s) in HEK293T cells. Treatment with anisomycin induced upshift of Nur77 bands ( Figure 2b ). The resulting slower migrating Nur77 bands were converted into a single faster migrating Nur77 band, after lysates from cells treated with anisomycin or TPA had been incubated with AP ( Figure 2c ). These results indicate that anisomycin treatment induced Nur77 phosphorylation. Anisomycin activates not only JNK but also p38 MAPK (Tournier et al., 2000) . To determine whether JNK activation mediated anisomycin-induced Nur77 phosphorylation, Nur77-transfected cells were treated with anisomycin together with JNK inhibitor, PD98059 or SB203580. Cotreatment of anisomycin with the JNK inhibitor, which completely blocked activation of JNK but not p38 by anisomycin, prevented the anisomycininduced upshift of Nur77 bands. In contrast, cotreatment with SB203580, which selectively inhibited anisomycin-activated p38, did not (Figure 2d ). Consistent with its inability to activate ERK, anisomycin-induced upshift was not affected by PD98059. Together, these results demonstrate that JNK activation is involved in Nur77 phosphorylation by anisomycin.
To study whether anisomycin-induced Nur77 phosphorylation regulated its nuclear export, cytoplasmic and nuclear fractions were prepared from Nur77-transfected cells treated with or without anisomycin and analysed for the presence of Nur77 by immunoblotting (Figure 2e ). The purity of the fractions was verified by their selective expression of nuclear protein PARP or cytoplasmic protein Hsp60. In the absence of anisomycin treatment, Nur77 was found in both the cytoplasmic and nuclear fractions. Interestingly, the majority of hypophosphorylated Nur77 protein was detected in the nuclear fraction, whereas hyperphosphorylated Nur77 protein was found mainly in the cytoplasmic fraction (Figure 2e ). When cells were treated with anisomycin, the majority of Nur77 was heavily phosphorylated and found predominantly in the cytoplasmic fraction. The fact that hyperphosphorylated Nur77 resides in the cytoplasm again demonstrates that JNK activation is involved in anisomycin-induced Nur77 nuclear export.
Phosphorylation of Nur77 by MEKK1and its regulation of Nur77 nuclear export
To further confirm the role of JNK activation in Nur77 nuclear export, we examined the effect of MEKK1 that is also known to activate JNK (Minden et al., 1994) . Expression of constitutively active MEKK1 (MEKK1-DA) induced upshift of fast-migrating Nur77 bands, similar to the effect of anisomycin. The upshift was largely abolished when MEKK1-DA was coexpressed with dominant-negative JNK (DN-JNK) that strongly suppressed MEKK1-DA-induced JNK activation (Figure 3a) , suggesting that JNK was mainly responsible for Nur77 phosphorylation by MEKK1. The role of MEKK1-DA-induced phosphorylation of Nur77 in its nuclear export was studied by cellular fractionation assays, which showed that the MEKK1-DA-induced high-molecular-weight Nur77 bands were only detected in the cytoplasmic fraction, whereas the fast-migrating Nur77 band was found in both nuclear and cytoplasmic fractions (Figure 3b ). Thus, JNK activation again is involved in MEKK1-induced Nur77 nuclear export.
JNKK2-JNK1 fusion protein prevents Nur77 nuclear accumulation Our investigations of 3-Cl-AHPC, TPA, anisomycin and MEKK1 suggest that JNK activation is essential for their induction of Nur77 nuclear export. However, these JNK upstream stimuli also activate other signaling pathways. To determine to what degree that the JNK activation plays a role, we next evaluated the effect of JNKK2-JNK1 fusion protein that exhibits constitutive JNK activity (Zheng et al., 1999) . The JNKK2-JNK1 fusion protein is specific for the JNK pathway, and it does not activate either p38 or ERK (Zheng et al., 1999) . Unlike JNK that exclusively resides in the cytoplasm, and upon activation translocates into the nucleus to phosphorylate its nuclear targets (Minden and Karin, 1997) , the JNKK2-JNK1 fusion resided in both the nucleus and the cytoplasm (Figure 4 ). When JNKK2-JNK1 was coexpressed with Nur77, Nur77 was also diffusely distributed throughout the cells, in contrast to its exclusive nuclear localization in the absence of JNKK2-JNK1 expression. The Nur77 distribution overlapped with that of JNKK2-JNK1, suggesting their possible association. The diffused distribution of Nur77 was observed even though JNKK2-JNK1 was coexpressed for 48 h, indicating that JNK activation alone is insufficient to induce Nur77 nuclear export. Therefore, it is likely that JNK acts to inhibit Nur77 nuclear accumulation, an event critical for the onset of Nur77 nuclear export.
Induction of Nur777 nuclear export by MEKK1 requires a prolonged MEKK1 activation Our previous study showed that coexpression of MEKK1-DA with GFP-Nur77 for 14 h did not alter the subcellular localization pattern of GFP-Nur77 (Kolluri et al., 2003) . Our current finding that coexpression of MEKK1-DA with Nur77 for 48 h caused the accumulation of phosphorylated Nur77 in the cytoplasm (Figure 3b ) prompted us to conduct a time course analysis of the effect of MEKK1-DA coexpression. HEK293T cells were transfected with GFP-Nur77 and MEKK1-DA expression vectors for various periods of time and the distribution of GFP-Nur77 was determined by confocal microscopy. In the absence of MEKK1-DA, GFP-Nur77 was found primarily in the nucleus, as revealed by confocal microscopy ( Figure 5) . At 24 h after cotransfecting GFP-Nur77 and MEKK1-DA, a small portion of GFP-Nur77 was diffusely distributed in the cytoplasm, whereas most GFP-Nur77 remained in the nucleus. This is similar to the effect of JNKK2-JNK1 fusion protein (Figure 4) . However, at 48 h, GFP-Nur77 was exclusively localized in the cytoplasm. Thus, a 48-h coexpression of MEKK1-DA was required for inducing Nur77 nuclear export, suggesting that a prolonged MEKK1 activation might modulate other signal pathways or expression levels of protein factors involved in Nur77 nuclear export.
To determine whether JNK phosphorylation of Nur77 was required for MEKK1-DA-induced Nur77 nuclear export, the Nur77 N-terminal sequence (amino acids 1-149), which is known to be phosphorylated by JNK (Kolluri et al., 2003) , was deleted. The mutant, Nur77/150-598, when cotransfected with MEKK1-DA into cells for 48 h, did not show any cytoplasmic localization ( Figure 5 ), indicating that the JNK phosphorylation region of Nur77 was required for its response to the MEKK1-DA effect. A previous report (Katagiri et al., 2000) indicated that NGF-induced NGFI-B nuclear export required the phosphorylation of Ser105 in NGFI-B (Ser140 in human Nur77) by ERK kinase. However, we found that replacement of Ser140 with Ala did not affect the ability of MEKK1-DA to induce Nur77/S140A nuclear export ( Figure 5 ). Thus, it is unlikely that ERK phosphorylation plays a role in MEKK1-DA-induced Nur77 nuclear export.
Role of Nur77 phosphorylation by Akt in MEKK1-induced Nur77 nuclear export The above observation that the Nur77 nuclear export required a 48-h period of MEKK1 activation suggested that other signaling pathways were required for MEKK1-induced Nur77 nuclear export. We, therefore, studied whether Akt, which is known to phosphorylate Nur77 (Masuyama et al., 2001; Pekarsky et al., 2001) , was involved. First, we examined the effect of 3-Cl-AHPC on Akt activation in H460 cells, in which 3-Cl-AHPC-induced Nur77 nuclear export was rapid, occurring within 1-6 h (Li et al., 2000; Cao et al., 2004; Lin et al., 2004) . Treatment of H460 cells with 3-Cl-AHPC strongly inhibited Akt activation (Figure 6a ). This inhibition was observed when cells were treated with 3-Cl-AHPC for as short time as 3 h. We also studied whether 3-Cl-AHPC regulated activity of p90-kDa ribosomal S6 kinase (RSK), a serine/threonine protein kinase and a downstream effector of MAPK (Frodin and Gammeltoft, 1999) , which was recently reported to phosphorylate Nur77 (Wingate et al., 2005) . Although TPA strongly activated RSK in H460 cells, 3-Cl-AHPC did not show a clear effect (Figure 6a ). These results suggested that Akt, but not RSK, might represent another signaling pathway involved in regulating Nur77 nuclear export by 3-Cl-AHPC. Indeed, 3-Cl-AHPC failed to induce Nur77 nuclear export when cells were grown in medium containing high levels of serum (data not shown).
We next studied whether constitutive activation of Akt inhibited MEKK1-DA-induced Nur77 nuclear export. For these experiments, GFP-Nur77 and MEKK1-DA were cotransfected into HEK293T cells for 48 h. Confocal microscopy showed that GFP-Nur77 was exclusively localized in the nucleus when GFPNur77 and MEKK1-DA were cotransfected with constitutively active Akt (CA-Akt), whereas GFP-Nur77 resided in the cytoplasm when cells were only transfected with MEKK1-DA and GFP-Nur77 (Figure 6b) . Thus, Akt activation inhibited MEKK1-DA-induced Nur77 nuclear export. Human Nur77 is phosphorylated by Akt at Ser351 (Ser350 in rat Nur77) (Masuyama et al., 2001; Pekarsky et al., 2001) . To study whether the effect of CA-Akt was due to its phosphorylation of Nur77, Ser351 of Nur77 was replaced with alanine. The resulting mutant, Nur77/S351A, resided in the nucleus, similar to wild-type Nur77 (data not shown). However, Nur77/S351A migrated to the cytoplasm when MEKK1-DA was cotransfected, and coexpression of CA-Akt did not affect its cytoplasmic localization (Figure 6b ). These results demonstrated that the phosphorylation of Ser351 was crucial for the inhibitory effect of CA-Akt on Nur77 nuclear export. We then examined whether inhibition of Akt activation accelerated MEKK1-DA-induced Nur77 nuclear export. For this purpose, MEKK1-DA and GFP-Nur77 were cotransfected for 24 h, which was insufficient to cause nuclear export of GFP-Nur77 (Figure 6c ). When GFPNur77 and MEKK1-DA were cotransfected with the dominant-negative Akt expression vector (DN-Akt), GFP-Nur77 was found exclusively in the cytoplasm (Figure 6c) . Moreover, coexpression of MEKK1-DA and GFP-Nur77/S351A for 24 h was able to cause the mutant to reside in the cytoplasm. The fact that these conditions were insufficient to induce the nuclear export of the wild-type Nur77 ( Figure 5 ) suggested that prevention of the phosphorylation of Nur77 by Akt facilitated Nur77 nuclear export. The role of Akt was also illustrated by the acceleration of MEKK1-DAinduced Nur77 nuclear export by inhibiting phosphatidylinositol 3-kinase (PI3-K) activity. Treatment of cells with the PI3-K inhibitor LY294002 led to the cytoplasmic localization of GFP-Nur77, even though MEKK1-DA had been cotransfected with GFP-Nur77 for only 24 h (Figure 6c ). Nuclear export of Nur77/S351A resulted from coexpression with MEKK1-DA for 24 h also depended on its phosphorylation by JNK, as the treatment of cells with the JNK inhibitor or its cotransfection with DN-JNK1 expression vector prevented the cytoplasmic localization of Nur77/S351A (Figure 6d) . Thus, Akt signaling pathway is involved in modulating MEKK1-induced Nur77 nuclear export through its phosphorylation of Nur77.
MEKK1 enhanced interaction of Nur77 with Bcl-2
We previously reported that Nur77 targeted mitochondria by binding to Bcl-2 . This interaction required the cytoplasmic localization of Nur77 because wild-type Nur77, which typically localized in the nucleus, interacted with Bcl-2 only when it had migrated to the cytoplasm in response to certain apoptotic stimuli . Our observation that MEKK1-DA induced Nur77 nuclear export prompted us to investigate whether MEKK1-DA could promote the interaction of Nur77 with Bcl-2. The Bcl-2 Figure 5 Induction of Nur77 nuclear export by MEKK1 requires a prolonged MEKK1 activation. HEK293T cells were transfected with GFP fusion constructs of wild-type or mutant Nur77 alone or with MEKK1-DA expression vector for either 24 or 48 h as indicated. Cells were immunostained with anti-MEKK1 antibody. GFP fluorescence and MEKK1 staining were visualized by confocal microscopy, and the images were overlaid. About 5-10% of MEKK1-DA-transfected cells showed Nur77 nuclear export after 24 h, whereas 90% showed Nur77 nuclear export after 48 h. GFP-Nur77/150-598 was not exported by MEKK1-DA cotransfection, whereas GFP-Nur77/S140A showed the same extent of nuclear export as wild-type GFP-Nur77. expression vector and Myc-tagged Nur77 (Myc-Nur77) were cotransfected into HEK293T cells in the absence or presence of MEKK1-DA for 48 h. In the absence of cotransfected MEKK1-DA, immunoprecipitation of Myc-Nur77 by anti-Myc antibody failed to coprecipitate Bcl-2, a finding that is consistent with our previous observation . However, the coexpression of MEKK1-DA for 48 h resulted in the significant precipitation of Bcl-2 by the anti-Myc antibody (Figure 7a ). The effect of MEKK1-DA on Nur77-Bcl-2 interaction was also illustrated by co-immunoprecipitation using anti-Bcl-2 antibody (Figure 7b ). In the absence of MEKK1-DA expression, the immunoprecipitation of Bcl-2 by anti-Bcl-2 antibody did not cause Myc-Nur77 coprecipitation. When MEKK1-DA was cotransfected for 48 h, Myc-Nur77 was significantly precipitated by anti-Bcl-2 antibody (Figure 7b ). The enhancement of Nur77-Bcl-2 interaction by MEKK1-DA was likely due to its induction of Nur77 nuclear export. This is demonstrated by our analysis of two Nur77 mutants, Nur77/DDBD and DC3. Nur77/DDBD lacks the Nur77 DNA-binding domain (DBD), whereas Nur77/DC3 contains only the Nur77 C-terminal region Lin et al., 2004) . Both mutants constitutively resided in the cytoplasm and interacted with Bcl-2 in the absence of JNK activators (Figure 7c ). Figure 6 Akt inhibits MEKK1-mediated nuclear export of Nur77 by phosphorylating the Ser351 residue of Nur77. (a) Effect of activation of Akt and RSK by 3-Cl-AHPC. H460 lung cancer cells were treated with 3-Cl-AHPC (1 mM) or TPA (100 ng/ml) for the indicated times. Cell extracts were prepared and analysed for Akt or RSK activation by determining the expression of phosphorylated Akt (P-Akt) or RSK (P-RSK) using antibody against phospho-Akt or phospho-RSK. Expression of a-tubulin was used as the loading control. (b) Activation of Akt inhibits MEKK1-DA-induced Nur77 nuclear export. HEK293T cells were transfected with GFP-Nur77 or GFP-Nur77/S351A alone or with MEKK1-DA and/or CA-Akt as indicated for 48 h. Cells were stained with anti-MEKK1 or antiAkt antibody, and examined by confocal microscopy. GFP-Nur77 and GFP-Nur77/S351A were exported at similar frequency (90%) after MEKK1-DA cotransfection for 48 h. Less than 10% of cells transfected with both MEKK1 and CA-Akt showed nuclear export of GFP-Nur77, whereas 70% for GFP-Nur77/S351A. (c) Inhibition of Akt activity accelerates MEKK1-induced Nur77 nuclear export. HEK293T cells were transfected with GFP-Nur77 or GFP-Nur77/S351A alone or with MEKK1-DA and/or DN-Akt in the absence or presence of PI3-K inhibitor LY294002 (20 mM) as indicated for 24 h. Cells were stained with anti-MEKK1 or anti-Akt antibody and examined by confocal microscopy. The percentages of cells showing GFP-Nur77 nuclear export under different conditions are: less than 10% on MEKK1-DA transfection; 50-60% on MEKK1-DA and DN-Akt cotransfection; and 30-40% on MEKK1-DA transfection plus LY294002 treatment. About 50% of GFP-Nur77/S351A-transfected cells displayed GFP-Nur77/S351A nuclear export. (d) MEKK1-induced nuclear export of Nur77/S351A is mediated by JNK activation. GFP-Nur77/S351A and MEKK1-DA expression vectors cells alone or with DN-JNK1 expression vector were transfected into HEK293T for 24 h in the presence or absence of JNK inhibitor. Cells were stained with anti-MEKK1 antibody and examined by confocal microscopy. The percentage of cells showing nuclear export of GFP-Nur77/S351A by MEKK1 transfection for 24 h (50%) decreased to 15 and 25% on JNK inhibitor treatment and DN-JNK1 cotransfection, respectively.
The addition of JNK activators or inhibitors did not affect the interaction of the mutants with Bcl-2 (data not shown). These results suggested that the role of MEKK1-DA was to induce the translocation of Nur77 from the nucleus to the cytoplasm. Once in the cytoplasm, Nur77 was able to bind Bcl-2 regardless of its phosphorylation by JNK.
Discussion
Nur77 is a unique nuclear receptor family member in that it exerts the opposing biological activities of survival and death. Our previous observations (Li et al., 2000; Lin et al., 2004) showing that Nur77 migrates from the nucleus to the mitochondria, where it binds Bcl-2 to trigger cytochrome c release and apoptosis demonstrate that the subcellular localization of Nur77 defines its biological activities. However, how the subcellular localization of Nur77 was regulated remained largely unknown. The activities of Nur77 are unlikely to be regulated by ligands, as recent studies revealed that Nur77 family members lack a classical ligand-binding pocket (Baker et al., 2003; Wang et al., 2003; Flaig et al., 2005) . Here, we provide evidence that the activities of JNK and Akt, which phosphorylate Nur77, are involved in regulating Nur77 nuclear export (Figure 8) .
A causal role of JNK activation in some death responses has been demonstrated (Lin and Dibling, 2002; Kanda and Miura, 2004) . JNK was activated rapidly in cells destined to undergo apoptosis under certain conditions, and overexpression of JNK resulted in apoptosis in some cell types. Inhibition of JNK activity by the antisense method or DN-JNK constructs could sometimes attenuate these apoptotic responses. The requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway was convincingly demonstrated in primary murine embryonic fibroblasts (Tournier et al., 2000) . Our present study showed that 3-Cl-AHPC activated JNK in various cancer cell lines (Figure 1a) . Treatment of cells with a JNK inhibitor potently inhibited the ability of 3-Cl-AHPC to induce the apoptosis of H460 lung cancer (Figure 1b) and other cancer cells, such as MGC80-3 gastric cancer cells (data not shown). These data are in Figure 7 MEKK1 enhances interaction of Nur77 with Bcl-2. (a, b) MEKK1 promotes interaction of Nur77 with Bcl-2. The indicated Myc-Nur77 (2 mg), Bcl-2 (2 mg), and MEKK1-DA (2 mg) expression vector alone or together were transfected into HEK293T cells. Cell lysates were immunoprecipitated by using monoclonal either antiMyc antibody (a) or polyclonal rabbit anti-Bcl-2 antibody (b). Lysates and immunoprecipitates were examined by immunoblotting using anti-Bcl-2 antibody (a) or anti-Myc antibody (b). Membranes were also blotted with anti-Myc (a) or anti-Bcl-2 antibody (b) to determine IP specificity and efficiency. Higher concentration SDS-PAGE (12%) was used in (a) to analyse immunoprecipitates so as to separate immunoprecipitated Bcl-2 from light chain IgG. (c) Nur77/DDBD and DC3 constitutively interact with Bcl-2. Myc-Nur77/DDBD or Myc-DC3 (2 mg) alone or with Bcl-2 (2 mg) expression vector was cotransfected into HEK293T cells. Cell lysates were immunoprecipitated by using polyclonal rabbit anti-Bcl-2 antibody. Cell lysates and immunoprecipitates were examined by immunoblotting using anti-GFP antibody. The same membranes were blotted with anti-Bcl-2 antibody to determine immunoprecipitation specificity and efficiency. Input represents 5% of cell lysates used in the co-immunoprecipitation assays. Figure 8 Role of JNK and Akt in mediating the effect of MEKK1 and 3-Cl-AHPC on Nur77 nuclear export. Our results demonstrate that 3-Cl-AHPC activates JNK and inhibits Akt in cells, in which 3-Cl-AHPC induces Nur77 nuclear export. Both the induction of Nur77 phosphorylation by JNK and the inhibition of Nur77 phosphorylation by Akt contribute to the translocation of Nur77 from the nucleus to the cytoplasm in response to 3-Cl-AHPC and MEKK1, where it targets mitochondria through interaction with Bcl-2, leading to cytochrome c release and apoptosis. It is likely that other protein factors and/or signal transduction pathways are also involved in the regulation of the Nur77-dependent apoptosis pathway. agreement with previous results (Zhang et al., , 2003 Wan et al., 2001; Garattini et al., 2004; BoisvieuxUlrich et al., 2005) , and they demonstrate that JNK activation is essential for the apoptotic effects of AHPN and its analogs.
Several lines of evidence are presented to demonstrate that the phosphorylation of Nur77 by JNK is involved in promoting Nur77 nuclear export. Inhibition of the activation of JNK induced by 3-Cl-AHPC by a JNK inhibitor abolished Nur77 nuclear export (Figure 1c) , indicating that JNK activation was required for 3-Cl-AHPC to induce Nur77 cytoplasmic localization. Consistently, other apoptotic stimuli, including TPA, VP16, and cisplatin (Li et al., 2000) , which induced Nur77 nuclear export, are known to activate JNK. Activation of JNK by TPA led to phosphorylation of both endogenous (Figure 2a ) and transfected (Figure 2b ) Nur77. The importance of JNK was further supported by the results of our examination of the effect of anisomycin, a potent activator of JNK and p38 MAPK (Tournier et al., 2000) . Treatment of cells with anisomycin resulted in the phosphorylation of Nur77 in a JNK-dependent manner (Figure 2 ), which correlated with its induction of Nur77 nuclear export (Figure 2e) . Expression of MEKK1-DA, an immediate upstream activator of JNK (Minden et al., 1994) , also resulted in Nur77 phosphorylation (Figure 3a) and Nur77 cytoplasmic localization (Figure 3b ), which were inhibited by either expression of DN-JNK1 or treatment with JNK inhibitor. The effect of MEKK1-DA on inducing Nur77 nuclear export was abolished by deleting the Nur77 N-terminal A/B domain ( Figure 5 ), which is phosphorylated by JNK (Kolluri et al., 2003) . Interestingly, this domain was required for apoptotic stimuli to induce Nur77 nuclear export (Li et al., 2000; Cao et al., 2004) . Thus, JNK phosphorylation of the Nur77 A/B domain is critical for the nuclear export of Nur77 in response to apoptotic stimuli.
Although JNK phosphorylation of Nur77 clearly plays a role in the induction of Nur77 nuclear export, JNK activation alone is insufficient to complete the process. This is demonstrated by our observation that coexpression of MEKK1-DA for 24 h, which was sufficient for JNK activation, resulted in only diffused distribution of Nur77 ( Figure 5 ). In addition, expression of JNKK2-JNK1 fusion protein with constitutive-active JNK activity was not able to induce exclusive localization of Nur77 in the cytoplasm. Instead, it caused diffused distribution of Nur77 throughout cells (Figure 4) . These results suggest that Nur77 phosphorylation by JNK may function to inhibit Nur77 nuclear accumulation, which is likely an early event of Nur77 nuclear export. Other signaling pathways or protein factors are therefore required to complete the process of nuclear export. Interestingly, Nur77 was found predominantly in the cytoplasm when cells were treated with anisomycin (Figure 2e ) or when MEKK1-DA was coexpressed for 48 h ( Figure 5 ). Thus, prolonged MEKK1 activation or anisomycin may regulate other signaling pathways or expression of protein factors required for Nur77 nuclear export.
The results obtained in this study demonstrate that phosphorylation of Nur77 by Akt represents another mechanism that regulates Nur77 nuclear export in response to certain stimuli. Previous studies revealed that Akt phosphorylated Ser351 of Nur77, leading to the inhibition of Nur77 DNA binding, transactivation and apoptotic activities (Masuyama et al., 2001; Pekarsky et al., 2001) . Akt mediates the anti-apoptotic effects of growth factors through PI3-K. It is also constitutively activated in many cancer cell lines and confers their survival activity (Datta et al., 1999) . A recent study showed that the induction of apoptosis by 3-Cl-AHPC involved the inhibition of Akt activity (Farhana et al., 2004) . Our results demonstrated that MEKK1-DA-induced Nur77 nuclear export was inhibited by cotransfection of CA-Akt (Figure 6b ). In addition, coexpression of MEKK1-DA and DN-Akt for 24 h induced Nur77 nuclear export (Figure 6c ), whereas expression of MEKK1-DA alone for 24 h did not. Consistent with these results, transfection of MEKK1-DA for 24 h induced Nur77 nuclear export in cells treated with the PI3-K inhibitor LY294002 (Figure 6c ). The inhibitory effect of Akt on Nur77 function was mediated by its phosphorylation of Nur77 at Ser351. This was illustrated by our finding that mutation of Ser351 to Ala prevented CA-Akt from inhibiting the induction of Nur77/S351A nuclear export by MEKK1-DA (Figure 6b) . Furthermore, expression of MEKK1-DA for 24 h was sufficient to induce nuclear export of Nur77/S351A (Figure 6c ). These results demonstrate that the inhibition of Nur77 nuclear export was caused by the phosphorylation of its Ser351 by Akt. Interestingly, the Ser351 residue is located next to the DBD. Deletion of the DBD and Ser351 from Nur77 gives the mutant Nur77/DDBD that constitutively targets mitochondria and induces apoptosis (Li et al., 2000; Lin et al., 2004) , implying that the phosphorylation of Nur77 by Akt at Ser351 represents an inhibitory regulatory mechanism on Nur77 nuclear export and Nur77-dependent apoptosis. In support of this conclusion, we observed that 3-Cl-AHPC effectively inhibited Akt activation in H460 lung cancer cells (Figure 6a ) and induced Nur77 nuclear export (Kolluri et al., 2003; Lin et al., 2004) . In addition, 3-Cl-AHPC was much more effective in inducing Nur77 nuclear export when cells were stressed by culturing them in serum-free medium Lin et al., 2004) . Although Akt inactivation is sufficient to induce Nur77 nuclear export in response to MEKK1 activation, it is noteworthy that expression of JNKK2-JNK1 failed to induce nuclear export of Nur77/S351A (data not shown). Similarly, anisomycin, which induces Nur77 nuclear export, does not inhibit Akt (data not shown), suggesting that other events regulated by anisomycin play a role. It is likely that protein factors, which positively or negatively regulate the complex process of Nur77 migration from the nucleus to the cytoplasm, are regulated by different signaling pathways in a cell type-specific manner.
The recent observation that RSK also phosphorylates Nur77 at Ser351 (Wingate et al., 2005) underscores the complexity of signal transduction pathways regulating Nur77 nuclear export. ERK2, an upstream activator of RSK (Frodin and Gammeltoft, 1999) , prohibits apoptosis-induced Nur77 nuclear export (Jacobs et al., 2004) , raising the possibility that phosphorylation of Ser351 by RSK may be responsible for the inhibitory effect of ERK2 on Nur77 nuclear export. TPA, which induces Nur77 nuclear export and apoptosis in LNCaP cells (Li et al., 2000; Lin et al., 2004) , is unable to induce Nur77 nuclear export in H460 lung cancer cells (data not shown), in which it strongly activates RSK (Figure 6a ). In contrast, 3-Cl-AHPC, an effective inducer of Nur77 nuclear export in H460 cells (Kolluri et al., 2003; Cao et al., 2004; Lin et al., 2004) , does not activate RSK in these cells (Figure 6a ). It remains to be seen whether and how RSK phosphorylation of Nur77 at Ser351 contributes to the regulation of Nur77 nuclear export by different stimuli, including MEKK1-DA known to activate ERK.
In summary, our results demonstrated that JNK and Akt are two important signaling pathways involved in regulating the subcellular localization of Nur77. Further studies are needed to fully unravel the molecular events governing Nur77 nuclear export in response to various stimuli.
Materials and methods

Plasmid constructs
The GFP-Nur77 fusion was constructed by cloning human Nur77 cDNA in frame into pGFP-N2 (Clontech). Deletion mutants of Nur77 were generated by standard restriction enzyme digestion or amplification by polymerase chain reaction. Point mutants of Nur77 were generated with a Quickchange site-directed mutagenesis kit (Stratagene) according to the manufacturer's recommendation. The constitutively active MEKK1 (MEKK1-DA) expression plasmid has been described (Kolluri et al., 2003) . DN-JNK was provided by Dr Dan Mercola (Sydney Kimmel Cancer Center). DN-Akt and CA-Akt were provided by Dr Thomas Mustelin (The Burnham Institute). JNKK2-JNK1 was kindly provided by Dr Anning Lin (University of Chicago).
Cell culture H460, H292 and A549 lung cancer cells and LNCaP prostate cancer cells were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). MDA-MB-231 breast cancer cells and HEK293T human embryonic kidney cells were grown in DME medium supplemented with 10% FBS. H460 cells stably expressing Nur77 antisense RNA were described previously (Li et al., 1998 (Li et al., , 2000 .
Apoptosis assays
For nuclear morphological change analysis, cells were trypsinized, washed with PBS, fixed with 3.7% paraformaldehyde, and stained with DAPI (4,6-diamidino-2-phenylindole) (50 mg/ml) to visualize nuclei by fluorescent microscopy (Li et al., 2000) .
In vitro JNK kinase assay The in vitro JNK assay was performed as described (Agadir et al., 1999) . After treatment with 3-Cl-AHPC (1 mM) in 0.5% FBS, total cell extracts were immunoprecipitated with anti-JNK1 antibody (Santa Cruz Biotechnology) and subjected to an in vitro kinase assay using GST-c-Jun (Stratagene) as a substrate. GST-c-Jun was incubated with the JNK1 immunoprecipitate and 2 mCi of [g-32 P]ATP (Amersham) in JNK reaction buffer (25 mM HEPES, pH 7.5, 10 mM magnesium acetate and 50 mM ATP) at 301C for 30 min and electrophoresed on a 10% polyacrylamide gel. The gel was dried and exposed to X-ray film levels of GST-c-Jun phosphorylation were determined by scanning X-ray film.
AP treatment
Cells were boiled for 10 min in AP lysis buffer (100 mM TrisHCl, pH 8.0, 100 mM NaCl, 5 mM MgCl 2 , 2 mM PMSF and 0.6% SDS) and incubated with AP (200 U/ml) (Boehringer Mannheim) for 4 h at 371C.
Immunoblotting
Cell lysates were boiled in sodium dodecyl sulfate (SDS) sample buffer, resolved by SDS-PAGE (8 or 12.5% polyacrylamide), and transferred to nitrocellulose. After transfer, the membranes were blocked in 5% milk in TBST (10 mM TrisHCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) for 30 min and incubated with primary antibody in 5% milk in TBST for 2 h at room temperature. The membranes were washed three times with TBST, and incubated for 1 h at room temperature in TBST containing horseradish peroxidase-linked antiimmunoglobulin. After three washes in TBST, immunoreactive products were detected by chemiluminescence with an enhanced chemiluminescence system (Amersham). The following antibodies were from Cell Signaling Technology: anti-phospho-p44/p42 MAPK (Thr202/Tyr204), anti-phosphop38(Thr180/Tyr182), anti-phospho-c-Jun (Ser63), anti-phospho-Akt (Ser473) and anti-phospho-RSK (Thr359/Ser363).
Co-immunoprecipitation assays
For co-immunoprecipitation assay , HEK293T cells grown in 10 cm dishes were transfected with Myc-Nur77 and Bcl-2 with or without MEKK1-DA expression plasmid. Transfected HEK293T cells were lysed in 300 ml of TAE buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaC1, 10 mM EDTA, and 1% NP-40) containing protease inhibitors (Sigma). Lysate was incubated with 1 mg of anti-Myc monoclonal antibody (Santa Cruz Biotechnology) or anti-Bcl-2 antibody (Santa Cruz Biotechnology) at 41C for 2 h. Immunocomplexes were then precipitated with 40 ml of protein A/G-sepharose (Santa Cruz Biotechnology). After extensive washing with TAE buffer, beads were boiled in 40 ml loading buffer and analysed by Western blotting. Mouse IgG (Santa Cruz Biotechnology) was used as a negative control.
Confocal microscopy
For staining for endogenous Nur77 (Li et al., 2000; Lin et al., 2004) , H460 cells were seeded in 24-well plates overnight and treated with 3-Cl-AHPC (1 mM) with or without JNK inhibitor II (Calbiochem) in medium containing 0.5% FBS for 3 h. The cells were fixed in 4% paraformaldehyde in PBS for 10 min and washed twice with PBS. Cells were then permeabilized with 0.1% Triton X-100 in PBS for 10 min. Fixed cells were pre-incubated for 30 min in PBS containing 5% BSA at room temperature. Cells were stained with monoclonal anti-NGFI-Ba antibody (1:200 dilution) (R&D), followed by antimouse IgG conjugated with Cy3 (1:1000 dilution) (Sigma). To detect mitochondria, cells were stained with anti-Hsp60 goat IgG (Santa Cruz), followed by anti-goat IgG conjugated with Cy3 (Sigma). To stain transfected proteins, 0.5 mg of GFP-Nur77 mutant fusion expression plasmid together with
